Attached files

file filename
8-K - 8-K - OURPETS COv423543_8k.htm

 

Exhibit 99.1

 

http:||www.ourpets.com|investor|includes|earnings|images|Q3_2013_img_0.jpg

 

 

FOR IMMEDIATE RELEASE

 

OurPet’s Company Reports Third Quarter 2015 Results

 

Record Q3 Net Revenue of Nearly $6.0 million -- Net Income Increases 428% to $410,450

 

FAIRPORT HARBOR, Ohio – November 2, 2015 --OurPet's Company (OTCQX: OPCO ) (www.ourpets.com), a leading proprietary pet supply company, today reported record third-quarter revenue of $5.99 million, an increase of 7% from $5.60 million in revenues for the comparable three months of 2014. Net income for the third quarter ended September 30, 2015, increased 428% to $410,450, or $0.02 diluted earnings per share, compared to $77,751, or $0.00, for the year prior.

 

Dr. Steven Tsengas, President and CEO commented, “We are pleased with our results for the third quarter in which we achieved record net revenue, gross margins improving to 34%, and net income from operations of almost 11% of sales. We continue to see strong sales growth in the Pet Specialty channel driven by our cat toys and bowls/feeder lines. E-commerce sales rebounded and grew 7% while the Food, Drug, Mass channel slightly decreased; however, we anticipate improved sales as the conversion to the PetZone brand is completed by year end. Unfortunately, with the strengthening of the U.S. dollar, international sales have been negatively impacted particularly in Canada and the United Kingdom.”

 

Dr. Tsengas continued, “We have expanded and strengthened our relationship with several domestic and international independent sales representative organizations, and have added another experienced salesperson to our staff. With the recent and anticipated introduction of a significant number of new innovative products in all our product categories, we are experiencing robust sales activity. Our Catty Whack™ , winner of the SuperZoo “Best New Cat Product”  award, is beginning to ship and is receiving strong consumer reaction. We expect to release more information on other major, trend-setting products over the next six months.

 

“As we have previously communicated, the last five years have been challenging for OurPet’s as we have transitioned from a small- to a medium-sized company poised for accelerated future growth in both revenue and net income. This required large investments in management/operating informational systems; strengthening and, where appropriate, adding management and professional/technical talent; improving warehousing and inventory management efficiencies; strengthening relationships of strategic domestic and overseas suppliers; and strengthening our relationship with our banking resources. We sincerely believe that these improvements will positively impact revenue and profit results going into the fourth quarter of 2015 and beyond.”

 

 

 

 

2015 Third Quarter Results

 

Net revenue increased 7% to $5,986,645 for the 2015 third quarter versus the same period last year. The $386,000 increase was attributable to strong sales in the Pet Specialty and Value channels, partially offset by a decrease in the Food, Drug and Mass channel.

 

Gross Profit was $2,012,177 for the 2015 third quarter compared to $1,640,751 the prior year. Gross profit margin increased 4.3 percentage points to 33.6% for the 2015 third quarter from 29.3% for the same period a year ago due to continuous improvement initiatives, price increases, and product mix.

 

Income from operations increased to $649,023 for the 2015 third quarter from $152,768 a year ago. This increase was primarily due to higher gross profit and also benefited from lower selling, general, and administrative expenses.

 

Other income for the 2015 third quarter increased to $14,582 from $6,051 a year ago due to a higher amount of patent infringement settlements.

 

Income before taxes was almost five times greater at $627,686 for the 2015 third quarter compared to $127,666 a year ago.

 

Income tax expense for the 2015 third quarter increased to $217,236 from $49,915 a year ago due to the higher income.

 

Net income increased to $410,450 for the 2015 third quarter from $77,751 last year. Net income per diluted share increased to $0.02 for the third quarter of 2015 from $0.00 a year ago.

 

EBITDA was $825,696 for the 2015 third quarter versus $323,140 a year ago. A reconciliation of EBITDA to GAAP net income is provided in an attachment to the summary financial statements.

 

2015 First Nine Months Results

 

Net revenue increased 6% to $17,170,795 for the first nine months of 2015. The year-over-year increase was due to strong Pet Specialty sales, especially in the bowls and feeders category.

 

Gross profit increased 15% to $5,424,591 for the first nine months of 2015 versus the prior year. Gross profit margin increased 2.5 percentage points to 31.6% for the first nine months of 2015 from 29.1% the prior year due to the same factors that benefited the 2015 third quarter results.

 

Income from operations increased 143% to $1,427,797 for the first nine months of 2015, which was attributable to higher gross profit and lower selling, general, and administrative expenses.

 

Other income decreased to $40,582 for the first nine months of 2015 from $77,713 for the same period last year due to a greater amount of patent infringement settlements in 2014.

 

Income before taxes increased to $1,383,158 for the first nine months of 2015 compared to $566,658 for the same period a year ago.

 

 

 

 

Income tax expense was $496,839 for the first nine months of 2015 compared to $206,723 the prior year.

 

Net income for the first nine months of 2015 increased 146% to $886,319 from $359,935 for the same period in 2014. Net income per share increased to $0.04 for the first nine months of 2015 from $0.02 last year.

 

EBITDA increased 72% to $1,984,688 the first nine months of 2015 compared to $1,153,656 the prior year. A reconciliation of EBITDA to GAAP Net Income is provided in an attachment to the summary financial statements.

 

The Current Ratio improved to 5.61, reflecting or strong liquidity, while Stockholders’ Equity improved by $904,319 or 12.1% over the comparable date last year.

 

About OurPet’s Company

 

OurPet’s Company designs, produces and markets a broad line of innovative, high-quality accessory and consumable pet products in the U.S. and overseas. Investors and customers may visit www.ourpets.com for more information about our company and its products. OurPet’s websites include www.petzonebrand.com and www.ourpets.com.

 

Forward-Looking Statements

 

Certain of the matters set forth in this press release are forward-looking and involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially are the following: business conditions; growth in the industry; general economic conditions; addition or loss of significant customers; the loss of key personnel; product development; competition; risks of doing business abroad; foreign government regulations; fluctuations in foreign currency rates; rising costs for raw materials and sources of supply that may be limited or unavailable from time to time; the timing of orders booked; and the other risks that are described from time to time in OurPet’s SEC reports. For further information, contact:

  

CONTACTS

OurPet’s Company
Dr. Steven Tsengas, CEO
(440) 343-6500, x111

 

DreamTeamNetwork
Austin, Texas
www.DreamTeamNetwork.com
512.758.8877 Office
Editor@DreamTeamNetwork.com

 

 

 

 

OURPET'S COMPANY AND SUBSIDIARIES

 CONSOLIDATED OPERATING RESULTS

 

   For the Three Months Ended   For the Nine Months Ended 
   September 30,   September 30, 
   2015      2014   2015     2014 
                 
Net revenue  $5,986,645   $5,601,011   $17,170,795   $16,175,692 
Cost of goods sold   3,974,468    3,960,260    11,746,204    11,462,593 
Gross profit on sales   2,012,177    1,640,751    5,424,591    4,713,099 
                     
Selling, general and administrative expenses   1,363,154    1,487,983    3,996,794    4,126,635 
                     
Income from operations   649,023    152,768    1,427,797    586,464 
                     
Other (income) and expense, net   (14,582)   (6,051)   (40,582)   (77,713)
Interest expense   35,919    31,153    85,221    97,519 
Income before taxes   627,686    127,666    1,383,158    566,658 
                     
Income Tax expense   217,236    49,915    496,839    206,723 
Net Income  $410,450   $77,751   $886,319   $359,935 
                     
                     
Basic and Diluted Net Income Per Common                    
Share After Dividend Requirements For Preferred                    
Stock  $0.02   $0.00   $0.04   $0.02 
                     
Weighted average number of common shares                    
outstanding used to calculate                    
basic earnings per share   17,562,239    17,056,910    17,558,085    16,884,581 
                     
Weighted average number of common and                    
equivalent shares outstanding used to calculate                    
diluted earnings per share   19,824,793    18,037,565    19,220,115    18,160,977 

  

 

 

 

OURPET'S COMPANY AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

   September 30,   December 31, 
   2015   2014 
ASSETS          
Cash and equivalents  $101,775   $192,448 
Receivables, net   4,048,759    3,116,448 
Inventories, net   7,802,675    6,894,115 
Prepaid expenses   467,126    478,593 
Total current assets   12,420,335    10,681,604 
           
LONG TERM ASSETS          
Property and equipment, net   1,867,252    1,769,548 
Amortizable intangible assets, net   361,259    384,063 
Non amortizable Intangible Assets   461,000    461,000 
Goodwill   67,511    67,511 
Deposits and Other assets   18,003    18,003 
Total long term assets   2,775,025    2,700,125 
           
Total assets  $15,195,360   $13,381,729 
           
LIABILITIES AND STOCKHOLDERS' EQUITY          
Current maturities of long-term debt   311,470    601,632 
Accounts payable   1,244,885    1,489,982 
Accrued expenses   656,652    565,491 
Total current liabilities   2,213,007    2,657,105 
           
LONG TERM LIABILITIES          
Long-term debt - less current portion above   938,894    119,780 
Revolving line of credit   3,473,032    2,862,032 
Deferred income taxes   204,947    281,651 
Total long term liabilities   4,616,873    3,263,463 
           
Total liabilities   6,829,880    5,920,568 
           
Stockholders' Equity   8,365,480    7,461,161 
           
Total liabilities and stockholders' equity  $15,195,360   $13,381,729 

 

 

 

 

EBITDA  Q3'15   Q3'14   1st nine months 2015   1st nine months 2014 
                 
Net Income  $410,450   $77,751   $886,319   $359,935 
Interest   35,919    31,153    85,221    97,519 
Tax Expense   217,236    49,915    496,839    206,723 
Depreciation   143,135    143,977    456,981    430,988 
Amortization   18,956    20,344    59,328    58,491 
Total EBITDA  $825,696   $323,140   $1,984,688   $1,153,656 

 

The above table reconciles the Company’s disclosure of Net Income per GAAP with the non GAAP financial measure EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization.) As the investment community has often requested the EBITDA calculation to help them evaluate performance, Management has chosen to provide this disclosure. Although EBITDA is widely used in the investment community as a benchmark to reflect operating performance, financing capability and liquidity, it is not regarded as a measure of operating performance and liquidity under generally accepted accounting principles (“GAAP”). It also does not represent cash flows from operating activities. In addition, the Company’s EBITDA may not be comparable to similar indicators provided by other companies. The Presentation of this additional information is not meant to be considered in isolation or as a substitute for net income (loss), or any component thereof, in accordance with GAAP.